These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28523979)

  • 21. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu.
    Mansouri S; Lietzau G; Lundberg M; Nathanson D; Nyström T; Patrone C
    PLoS One; 2016; 11(6):e0156867. PubMed ID: 27305000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase-activating polypeptide regulates forebrain neural stem cells and neurogenesis in vitro and in vivo.
    Ohta S; Gregg C; Weiss S
    J Neurosci Res; 2006 Nov; 84(6):1177-86. PubMed ID: 16941483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose Tissue Expression of PACAP, VIP, and Their Receptors in Response to Cold Stress.
    Cline DL; Short LI; Forster MAM; Gray SL
    J Mol Neurosci; 2019 Jul; 68(3):427-438. PubMed ID: 29982965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP).
    Tsumuraya T; Ohtaki H; Song D; Sato A; Watanabe J; Hiraizumi Y; Nakamachi T; Xu Z; Dohi K; Hashimoto H; Atsumi T; Shioda S
    J Neuroinflammation; 2015 Feb; 12():35. PubMed ID: 25889720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells.
    Nishimoto M; Furuta A; Aoki S; Kudo Y; Miyakawa H; Wada K
    Glia; 2007 Feb; 55(3):317-27. PubMed ID: 17115416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation.
    Sayasith K; Brown KA; Sirois J
    Reproduction; 2007 Feb; 133(2):441-53. PubMed ID: 17307912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation.
    Nicot A; Lelièvre V; Tam J; Waschek JA; DiCicco-Bloom E
    J Neurosci; 2002 Nov; 22(21):9244-54. PubMed ID: 12417650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
    Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
    Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
    Sano H; Miyata A; Horio T; Nishikimi T; Matsuo H; Kangawa K
    Regul Pept; 2002 Nov; 109(1-3):107-13. PubMed ID: 12409222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
    Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion.
    Lutz-Bucher B; Monnier D; Koch B
    Neuroendocrinology; 1996 Aug; 64(2):153-61. PubMed ID: 8857610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.
    Watanabe J; Nakamachi T; Matsuno R; Hayashi D; Nakamura M; Kikuyama S; Nakajo S; Shioda S
    Peptides; 2007 Sep; 28(9):1713-9. PubMed ID: 17719696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
    Braas KM; May V
    Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.